Gerresheimer Stock - Wednesday update on operations and strategy
17.06.2026 - 16:49:34 | ad-hoc-news.de
Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 16:47 CET. Details in the imprint.
Gerresheimer (DE000A0LD6E6) is a German specialist for pharmaceutical primary packaging and drug-delivery solutions listed on Xetra in Frankfurt. On Wednesday, the focus is on how the company executes its operational strategy in glass and plastic packaging, smart vials and customized solutions for pharma clients.
All news and key data on Gerresheimer stock
Background pieces, prior coverage and price data on Gerresheimer stock are bundled in the ad hoc news topic overview.
Operations and strategic positioning
Gerresheimer positions itself as a specialist for glass and plastic primary packaging, complex drug-delivery systems and customized solutions for pharmaceutical and biotech customers worldwide, with a focus on regulated healthcare markets in Europe and North America.
The company’s portfolio spans vials, ampoules, syringes, cartridges and inhaler and injection systems, as well as packaging for diagnostics, medical technology, cosmetics and selected food and beverage applications.
Recent initiatives and smart packaging
Operationally, Gerresheimer has been expanding its offerings in smart and traceable packaging, including a SmartTrack vial system designed to support safer medication administration and digital documentation at the point of care.
Such solutions aim to integrate machine-readable codes and digital features into primary packaging, targeting fewer medication errors and smoother workflows in hospitals and other healthcare settings.
What the company sells
Gerresheimer generates revenue primarily with pharmaceutical primary packaging made of glass and plastic, including vials, ampoules, prefillable syringes and cartridges, alongside inhalers and injection devices and tailored packaging concepts for pharma and biotech clients worldwide.
Where the stock trades today
The shares of Gerresheimer (DE000A0LD6E6) trade on Xetra in Frankfurt under the ticker GXI at around EUR 24.46 as of 06/17/2026, 16:47 CET.
Key facts on Gerresheimer stock
- Company: Gerresheimer AG
- ISIN: DE000A0LD6E6
- WKN: A0LD6E
- Ticker: GXI
- Venue: Xetra
- Price (as of 06/17/2026, 16:47 CET): 24.46 EUR
- Market cap: 761 million EUR (as of 06/17/2026)
- Sector / Industry: Health Care - Pharmaceutical packaging and drug-delivery
- Index membership: MDAX
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
